Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ: A011040)
Health Care · Pharmaceuticals · KR
₩5,050.00
-1.37% today · -14.0% 1Y
Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ: A011040) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $98.17M.
Over the last twelve months the share price has lost 14.0%, trading between 4.70K and 6.89K.
Tweenvest scores Kyung Dong Pharmaceutical Co., Ltd. across four factors: quality 64/100, value 74/100, dividend 90/100. Its strongest factor is dividend.
A011040 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $98.17M
- Revenue (TTM)
- $130.25M
- P/E
- 11.85
- EPS
- 426.02
- Dividend yield
- 5.94%
- Beta (5Y)
- 0.38
- 52-week high
- ₩6,890.00
- 52-week low
- ₩4,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 26.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.